Targeting Src in endometriosis-associated ovarian cancer

The SRC proto-oncogene is commonly overexpressed or activated during cancer development. Src family kinase inhibitors are approved for the treatment of certain leukemias, and are in clinical trials for the treatment of solid tumors. Src signaling is activated in endometriosis, a precursor of clear c...

Descripción completa

Detalles Bibliográficos
Autores principales: Manek, R, Pakzamir, E, Mhawech-Fauceglia, P, Pejovic, T, Sowter, H, Gayther, S A, Lawrenson, K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5007828/
https://www.ncbi.nlm.nih.gov/pubmed/27526105
http://dx.doi.org/10.1038/oncsis.2016.54

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5007828/
https://www.ncbi.nlm.nih.gov/pubmed/27526105
http://dx.doi.org/10.1038/oncsis.2016.54

Ejemplares similares